High concentrations of pyridoxal stimulate the expression of IGFBP1 in HepG2 cells through upregulation of the ERK/c-Jun pathway

Molecular Medicine Reports

Volumn 8, Issue 4, 2013, Pages 973-978

  Zhang, Peipei ^a   Suidasari, Sofya ^a   Hasegawa, Tomomi ^a   Yanaka, Noriyuki ^a   Kato, Norihisa ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Cancer; Cardiovascular disease; HepG2 cells; IGFBP1; Pyridoxal

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYCLOHEXIMIDE; DNA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN C JUN; PYRIDOXAL; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAMINE; PYRIDOXINE; SOMATOMEDIN BINDING PROTEIN 1; IGFBP1 PROTEIN, HUMAN; PROTEIN SYNTHESIS INHIBITOR; VITAMIN B COMPLEX;

ARTICLE; CANCER CELL; CARDIOVASCULAR DISEASE; CELL ISOLATION; CELL LYSATE; CELL STRAIN HEPG2; CELL STRAIN HT29; COLON CARCINOMA; CONTROLLED STUDY; CULTURE MEDIUM; DNA MICROARRAY; DRUG EFFECT; HUMAN; HUMAN CELL; LIVER; LIVER CELL CARCINOMA; NEOPLASM; PROPHYLAXIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; CELL PROLIFERATION; DRUG EFFECTS; GENETICS; HEPG2 CELL LINE; HT 29 CELL LINE; METABOLISM; PHYSIOLOGY; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

CELL PROLIFERATION; CYCLOHEXIMIDE; HEP G2 CELLS; HT29 CELLS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; MAP KINASE SIGNALING SYSTEM; PROTEIN BIOSYNTHESIS; PROTEIN SYNTHESIS INHIBITORS; PYRIDOXAL; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION; VITAMIN B COMPLEX;

EID: 84883323308     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1629     Document Type: Article

References (35)

1. Ishihara J, Otani T, Inoue M, Iwasaki M, Sasazuki S and Tsugane S; Japan Public Health Center-based Prospective Study Group: Low intake of vitamin B-6 is associated with increased risk of colorectal cancer in Japanese men. J Nutr 137: 1808-1814, 2007.
2. Theodoratou E, Farrington SM, Tenesa A, McNeill G, Cetnarskyj R, Barnetson RA, Porteous ME, Dunlop MG and Campbell H: Dietary vitamin B6 intake and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 17: 171-182, 2008.
3. Larsson SC, Orsini N and Wolk A: Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies. JAMA 303: 1077-1083, 2010.
4. Zhang XH, Ma J, Smith-Warner SA, Lee JE and Giovannucci E: Vitamin B6 and colorectal cancer: current evidence and future directions. World J Gastroenterol 19: 1005-1010, 2013.
5. Komatsu SI, Watanabe H, Oka T, Tsuge H, Nii H and Kato N: Vitamin B-6-supplemented diets compared with a low vitamin B-6 diet suppress azoxymethane-induced colon tumorigenesis in mice by reducing cell proliferation. J Nutr 131: 2204-2207, 2001.
6. Komatsu S, Watanabe H, Oka T, Tsuge H and Kat N: Dietary vitamin B6 suppresses colon tumorigenesis, 8-hydroxyguanosine, 4-hydroxynonenal, and inducible nitric oxide synthase protein in azoxymethane-treated mice. J Nutr Sci Vitaminol (Tokyo) 48: 65-68, 2002.
7. Komatsu S, Yanaka N, Matsubara K and Kato N: Antitumor effect of vitamin B6 and its mechanisms. Biochim Biophys Acta 1647: 127-130, 2003.
8. Kayashima T, Tanaka K, Okazaki Y, Matsubara K, Yanaka N and Kato N: Consumption of vitamin B6 reduces colonic damage and protein expression of HSP70 and HO-1, the anti-tumor targets, in rats exposed to 1,2-dimethylhydrazine. Oncol Lett 2: 1243-1246, 2011.
9. Yanaka N, Koyama TA, Komatsu S, Nakamura E, Kanda M and Kato N: Vitamin B6 suppresses NF-kappaB activation in LPS-stimulated mouse macrophages. Int J Mol Med 16: 1071-1075, 2005
10. Diffley JF: Affinity labeling the DNA polymerase alpha complex. I. Pyridoxal 5'-phosphate inhibition of DNA polymerase and DNA primase activities of the DNA polymerase alpha complex from Drosophila melanogaster embryos. J Biol Chem 263: 14669-14677, 1988.
11. Matsubara K, Matsumoto H, Mizushina Y, Lee JS and Kato N: Inhibitory effect of pyridoxal 5'-phosphate on endothelial cell proliferation, replicative DNA polymerase and DNA topoisomerase. Int J Mol Med 12: 51-55, 2003.
12. Martial J, Zaldivar J, Bull P, Venegas A and Valenzuela P: Inactivation of rat liver RNA polymerases I and II and yeast RNA polymerase I by pyridoxal 5'-phosphate. Evidence for the participation of lysyl residues at the active site. Biochemistry 14: 4907-4911, 1975.
13. Vermeersch JJ, Christmann-Franck S, Karabashyan LV, Fermandjian S, Mirambeau G and Der Garabedian PA: Pyridoxal 5'-phosphate inactivates DNA topoisomerase IB by modifying the lysine general acid. Nucleic Acids Res 32: 5649-5657, 2004.
14. Matsubara K, Mori M, Matsuura Y and Kato N: Pyridoxal 5'-phosphate and pyridoxal inhibit angiogenesis in serum-free rat aortic ring assay. Int J Mol Med 8: 505-508, 2001.
15. Lee PD, Giudice LC, Conover CA and Powell DR: Insulin-like growth factor binding protein-1: recent findings and new directions. Proc Soc Exp Biol Med 216: 319-357, 1997.
16. Yee D, Jackson JG, Kozelsky TW and Figueroa JA: Insulin-like growth factor binding protein 1 expression inhibits insulin-like growth factor I action in MCF-7 breast cancer cells. Cell Growth Differ 5: 73-77, 1994.
17. Van den Berg CL, Cox GN, Stroh CA, Hilsenbeck SG, Weng CN, McDermott MJ, Pratt D, Osborne CK, Coronado-Heinsohn EB and Yee D: Polyethylene glycol conjugated insulin-like growth factor binding protein-1 (IGFBP-1) inhibits growth of breast cancer in athymic mice. Eur J Cancer 33: 1108-1113, 1997
18. Zhang X and Yee D: Insulin-like growth factor binding protein-1 (IGFBP-1) inhibits breast cancer cell motility. Cancer Res 62: 4369-4375, 2002.
19. Ngo TH, Barnard RJ, Leung PS, Cohen P and Aronson WJ: Insulin-like growth factor I (IGF-I) and IGF binding protein-1 modulate prostate cancer cell growth and apoptosis: possible mediators for the effects of diet and exercise on cancer cell survival. Endocrinology 144: 2319-2324, 2003
20. Wei EK, Ma J, Pollak MN, Rifai N, Fuchs CS, Hankinson SE and Giovannucci E: A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 14: 850-855, 2005
21. Le Marchand L, Wang H, Rinaldi S, Kaaks R, Vogt TM, Yokochi L and Decker R: Associations of plasma C-peptide and IGFBP1 levels with risk of colorectal adenoma in a multiethnic population. Cancer Epidemiol Biomarkers Prev 19: 1471-1477, 2010
22. Rajwani A, Ezzat V, Smith J, Yuldasheva NY, Duncan ER, Gage M, Cubbon RM, Kahn MB, Imrie H, Abbas A, Viswambharan H, Aziz A, Sukumar P, Vidal-Puig A, Sethi JK, Xuan S, Shah AM, Grant PJ, Porter KE, Kearney MT and Wheatcroft SB: Increasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosis. Diabetes 61: 915-924, 2012
23. Taub R: Liver regeneration 4: transcriptional control of liver regeneration. FASEB J 10: 413-427, 1996
24. Leu JI, Crissey MA, Craig LE and Taub R: Impaired hepatocyte DNA synthetic response posthepatectomy in insulin-like growth factor binding protein 1-deficient mice with defects in C/EBP beta and mitogen-activated protein kinase/extracellular signal-regulated kinase regulation. Mol Cell Biol 23: 1251-1259, 2003
25. Ink SL and Henderson LM: Vitamin B6 metabolism. Ann Rev Nutr 4: 455-470, 1984
26. Nakari M, Kanouchi H and Oka T: High dose of pyridoxine induces IGFBP-3 mRNA expression in MCF-7 cells and its induction is inhibited by the p53-specific inhibitor pifithrin. J Nutr Sci Vitaminol (Tokyo) 57: 280-284, 2011
27. Frost RA, Nystrom GJ and Lang CH: Stimulation of insulin-like growth factor binding protein-1 synthesis by interleukin-1beta: requirement of the mitogen-activated protein kinase pathway. Endocrinology 141: 3156-3164, 2000
28. Leu JI, Crissey MA, Leu JP, Ciliberto G and Taub R: Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury. Mol Cell Biol 21: 414-424, 2001
29. Magne L, Blanc E, Marchand A, Fafournoux P, Barouki R, Rouach H and Garlatti M: Stabilization of IGFBP1 mRNA by ethanol in hepatoma cells involves the JNK pathway. J Hepatol 47: 691-698, 2007
30. Kanouchi H, Shibuya M, Tsukamoto S, Fujimura Y, Tachibana H, Yamada K and Oka T: Comparisons of uptake and cell surface binding among pyridoxal, pyridoxine, and pyridoxamine in RAW264.7 cells. Nutrition 26: 648-652, 2010.
31. Lumeng L, Brashear RE and Li TK: Pyridoxal 5'-phosphate in plasma: source, protein-binding, and cellular transport. J Lab Clin Med 84: 334-343, 1974.
32. Anderson BB, O'Brien H, Griffin GE and Mollin DL: Hydrolysis of pyridoxal-5'-phosphate in plasma in conditions with raised alkaline phosphate. Gut 21: 192-194, 1980.
33. Sakurai T, Asakura T, Mizuno A and Matsuda M: Absorption and metabolism of pyridoxamine in mice. I. Pyridoxal as the only form of transport in blood. J Nutr Sci Vitaminol (Tokyo) 37: 341-348, 1991.
34. Leppä S, Saffrich R, Ansorge W and Bohmann D: Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation. EMBO J 17: 4404-4413, 1998.
35. Shen J, Lai CQ, Mattei J, Ordovas JM and Tucker KL: Association of vitamin B-6 status with inflammation, oxidative stress, and chronic inflammatory conditions: the Boston Puerto Rican Health Study. Am J Clin Nutr 91: 337-342, 2010.